Driving Positive Progress for Sites

The Site Advisory Council (SAC) is a collaborative group of leaders from clinical research sites dedicated to enabling more efficient clinical trials. The Council brings actionable solutions to systemic industry challenges, focusing on initiatives that will drive positive progress for the majority of research sites.
Members represent diverse institutions representing leading clinical research organizations across the country.
Veeva facilitates the SAC by providing platform resources, public policy support, and connections to Sponsors to secure industrywide buy-in for solutions.
In Dialogue

About the Council

The Site Advisory Council brings together a diversity of clinical research leaders
organized into 3 distinct Working Groups
Picture1

10

Council Members

Picture1-2

3

Working Groups

Picture1-1

10

Research Institutions

Site Advisory Council
Site Advisory Council at Veeva North America R&D Summit, 2026

Addressing the burden of redundant or irrelevant training requirements.

The working group is focused on how Site Initiation Visit Training translate into early operational friction, with the goal of  identifying pathways that directly improve clinical trial readiness, execution, and early operational performance.

Initiatives:

The Site Initiation Visit (SIV) Training Effectiveness Survey is the first of its kind, intended to collect industry-wide data on site initiation visit quality and effectiveness. It correlates "Readiness Gaps" and initial patient enrollment to identify how early training impacts downstream clinical performance in interventional clinical trials.

Responses gathered will be used for quality analysis and anonymized before being leveraged for insights. 

Focusing on financial management challenges, with emphasis on the prevalent issues around clinical research sites not being paid on time or in accordance with their clinical trial agreements.

Initiatives:

The members have developed a sponsor payments survey to capture real world data on complications with payment timeliness. This will enable  insights which can be leveraged to improve this process across sites and sponsors.

 

Optimizing feasibility processes, with focus on reducing redundancy and improving efficiency.

Initiatives: 

The group is currently developing a standardized set of feasibility questions, which when leveraged across sponsors, can reduce survey turnaround times and site burden.

A site-driven pilot of these standardized questions is underway. Participating sites will fill out the standard questions and proactively share them with sponsors prior to completing brand new feasibility requests. 

Meet the Site Advisory Council Members

 Uniting distinguished clinical research site leaders

Training Working Group

Streamlining training requirements

Meghan Blair

Academic Site Advocate

Tina Bowdish

Director Research Network Development

Krista Snyder

Regulatory Affairs Manager

Feasibility Working Group

Addressing feasibility inefficiency 

Christina Brennan

Senior Vice President, Clinical Research

Danielle Rao

Clinical Research Program Manager

Keith Snyder-Dyer

Executive Director of Clinical Research

Theresa Oswald

Director, Research Operations and Conduct

Sponsor Payments Working Group

Improving sponsor payment efficiency

Adnan Rangwala

Senior Director, Research IT

Bishoy Anastasi

Sr. Director, Clinical Research Finance & Strategy

Want to Know More?

The Site Advisory Council presented its findings at
Veeva North America R&D Summit.
Join us next year for more insights!

October 11-13 in Boston

Summit is free to attend!